A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors

Sidney Kimmel Cancer Center, Philadelphia

Johns Hopkins University, Baltimore

Duke University, Durham

Emory University, Atlanta

Orlando Health Cancer Institute, Orlando

Sarah Cannon Research Institute - Tennessee Oncology, Nashville

University of Michigan, Ann Arbor

START Midwest, LLC, Grand Rapids

The University of Iowa, Iowa City

Stephenson Cancer Center, Oklahoma City

South Texas Accelerated Research Theraputics (START), LLC, San Antonio

Banner MD Anderson Cancer Center, Gilbert

Cedars-Sinai Medical Center, Los Angeles

University of California Los Angeles, Los Angeles

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston